Ken R. Bundell - Concepedia

Author

Ken R. Bundell

Also Known As

K R Bundell, Ken Bundell, Ken R. Bundell

Publications

495

Citations

H-Index

Concepts

All Affiliations

Ken R. Bundell is an author at AstraZeneca (United Kingdom) specializing in medicine, signal transduction, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	401
2	Cell Biology	2	2	401
3	Natural Sciences	1	1	385
4	Biochemistry	1	1	385
5	Biomolecular Engineering	1	1	385

Ken R. Bundell

Publications

418

Citations

H-Index

Page 1

	Year	Citations
Characterisation of cell‐penetrating peptide‐mediated peptide delivery Simon W. Jones, Richard Christison, Ken R. Bundell, British Journal of Pharmacology Peptide EngineeringPeptide SciencePeptide TherapeuticsPeptide ChemistryAnalytical Ultracentrifugation	2005	385
Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system. David Aharony, J Little, Stephen Joseph Powell, Molecular Pharmacology	1993	17
A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin Sabina Cosulich, Neil H. James, M. Needham, Carcinogenesis MitophagyLipid PeroxidationApoptosisImmunologyCell Death	2000	16

Page 1